Skip to page content

Opioids

Featured

Commentary

Tackle Fentanyl like a Poisoning Outbreak, Not a Drug Epidemic

Sep 3, 2019

America's fentanyl problem is far deadlier than past crises with other illegal drugs. New ideas, be they public policies, technologies or law enforcement strategies, are desperately needed. Continuing to treat fentanyl just like previous drug epidemics will likely be insufficient and may condemn thousands more to early deaths.
Research Brief

Understanding America's Surge in Fentanyl and Other Synthetic Opioids

Oct 7, 2019

Although overdose deaths from heroin and prescription opioids have declined, deaths involving synthetic opioids are on the rise. Much of the current wave of overdoses is linked to one synthetic opioid: fentanyl.

Explore Opioids

Testimony

Testimony

Addressing the U.S. Opioid Crisis: Using an Integrated Systems-Based Approach: Addendum

Document submitted January 21, 2020, as an addendum to testimony before the Senate Judiciary Committee Hearing on Opioids on December 17, 2019.

Jan 20, 2020
Blog

U.S.-Turkish Relations, Airports, Opioids: RAND Weekly Recap

This weekly recap focuses on the future of the U.S.-Turkish partnership, helping America's commercial airports meet rising demand, the opioid crisis, and more.

Jan 17, 2020
Essay

Fentanyl: The Most Dangerous Illegal Drug in America

America's fentanyl crisis is unlike previous drug epidemics and is likely to get worse. Deaths involving it and other synthetic opioids have surged from around 3,000 in 2013 to more than 30,000 in 2018. Solving the problem requires innovative approaches and unprecedented resources.

Jan 13, 2020
Journal Article

Growth and Distribution of Buprenorphine-Waivered Providers in the United States, 2007–2017

This study sheds light on the distribution of buprenorphine-waivered prescribers over the past decade. Growth has been rapid in communities affected by the opioid crisis, but slower in rural communities, and those with lower levels of education.

Jan 8, 2020
Periodical

Periodical

RAND Review: January-February 2020

Feature stories spotlight research on America's fentanyl crisis and new approaches to clinical guideline development. The Commentary column features terrorism expert Colin Clarke on the threat of white supremacists in the United States.

Jan 6, 2020
Blog

Preventing the Winter Blues, North Korea, Opioids: RAND Weekly Recap

This weekly recap focuses on how to ward off the winter blues, Kim Jong Un's latest threat, how to spend opioid settlement funds, and more.

Jan 3, 2020
Blog

Most Popular RAND Research of 2019

The search for lasting solutions to difficult policy problems starts with facts. Here are the 10 research projects that rand.org readers engaged with the most in 2019.

Dec 24, 2019
Commentary

Where Science Says to Spend Any U.S. Opioid Settlement Money

A global settlement with pharmaceutical companies has started to appear more and more likely. Even with billions of dollars, the settlement resources won't be unlimited. To avoid mistakes made in the tobacco master settlement agreement, any opioid funds must be carefully allocated.

Dec 19, 2019
Journal Article

Journal Article

Opioid Litigation and Maternal-Child Health: Investing in the Future

Funds from opioid litigation should be allocated in a way that benefits those most affected and reduces the risk of future harm.

Dec 19, 2019
Multimedia

Addressing the U.S. Opioid Crisis: Using an Integrated Systems-Based Approach

An overview of testimony by Bradley D. Stein presented before the Senate Judiciary Committee on December 17, 2019.

Dec 17, 2019
Testimony

Approaching the U.S. Opioid Crisis as an Ecosystem

Policymakers should think of the opioid crisis as an ecosystem and consider how its many parts interact—especially in unexpected ways. A broader view of the crisis will help those confronting it better prepare for the challenges ahead.

Dec 17, 2019
Blog

Celebrating a Milestone in Drug Policy Research

In 1989, RAND founded a new Drug Policy Research Center to provide rigorous, nonpartisan research to inform the debate on how to best address America's drug problem. Thirty years later, the center continues to do what it was created to do: improve the understanding of substance use and assess the consequences of an expanding range of drug policies.

Dec 12, 2019
Content

An In-Depth Look at the Opioid Epidemic

Opioids are powerful medicine for pain management. But many factors, including over-prescribing, misuse, and addiction, have led to a national health crisis. As policymakers and affected members of the public look for solutions, RAND Health Care examines potential policies and interventions to address both the causes and effects of the opioid crisis.

Dec 10, 2019
Journal Article

Journal Article

An Observational Study of Retail Pharmacy Naloxone Prescriptions: Differences Across Provider Specialties and Patient Populations

This article explores variation in pharmacy-dispensed naloxone by prescriber specialty and patient characteristics.

Dec 6, 2019
Journal Article

Journal Article

Strengths and Weaknesses of Existing Data Sources to Support Research to Address the Opioids Crisis

We conducted a scoping study to identify data sources and linking strategies commonly used in opioid studies, describe data source strengths and limitations, and highlight opportunities to use data to address public health research questions.

Dec 5, 2019
Blog

Artificial Intelligence Bias, Russia, Fentanyl: RAND Weekly Recap

This weekly recap focuses on bias in algorithms, Russia's limits in the Middle East, understanding the fentanyl crisis, and more.

Nov 29, 2019
Commentary

What Will the Opioid Crisis Look Like in Five Years?

Evidence suggests that once a synthetic opioid like fentanyl becomes dominant in a drug market, it stays that way. With that in mind, the United States should prepare for these drugs as a lasting phenomenon.

Nov 18, 2019
Journal Article

Association of Punitive and Reporting State Policies Related to Substance Use in Pregnancy With Rates of Neonatal Abstinence Syndrome

State policies that impose punitive action against pregnant women who use illicit substances are associated with higher rates of infants being born with opioid withdrawal.

Nov 15, 2019
News Release

Punishing Pregnant Women for Substance Use Is Linked to Higher Rates of Newborns Experiencing Opioid Withdrawal

State policies that impose punitive action against pregnant women who use illicit substances are associated with higher rates of infants being born with opioid withdrawal. This suggests that policymakers should instead focus on public health approaches that bolster prevention and expand access to treatment.

Nov 13, 2019
Commentary

Synthetic Opioid Crisis Still Growing, Often Among Unwitting Users

Although opioid prescriptions in the U.S. have fallen, opioid overdose deaths remain at historic levels. The continued spread of fentanyl and other illicitly manufactured synthetic opioids suggests the problem could still get worse.

Oct 14, 2019

1
2
3
4
5
6
7
8
9
Next